US Patent Issued to Pfizer on May 26 for "Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof" (New Jersey, New York Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,374, issued on May 26, was assigned to Pfizer Inc. (New York).

"Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof" was invented by Annaliesa Sybil Anderson (Upper Saddle River, N.J.), Caitlyn Gallagher (Ringwood, N.J.), Jianxin Gu (Paramus, N.J.), Isis Kanevsky (New York), Jin-Hwan Kim (Suffern, N.Y.), Justin Keith Moran (West Nyack, N.Y.), Suddham Singh (Monroe, N.Y.) and Naveen Surendran (Dumont, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to new conjugated capsular saccharide antigens (glycoconjugates), immunogenic compositions comprising said glycoconjugates and uses...